Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 601 to 625 of 2422

Published guidance, NICE advice and quality standards
TitleReference numberPublishedLast updated
Nintedanib for treating progressive fibrosing interstitial lung diseasesTA747
SeHCAT (tauroselcholic [75 selenium] acid) for diagnosing bile acid diarrhoeaDG44
Acute heart failure: diagnosis and managementCG187
Heart valve disease presenting in adults: investigation and managementNG208
Upadacitinib for treating moderate rheumatoid arthritisTA744
NBTXR-3 for treating advanced soft tissue sarcoma (terminated appraisal)TA745
Inducing labourNG207
Inducing labourQS60
Selpercatinib for treating advanced thyroid cancer with RET alterationsTA742
24/7 EEG SubQ for epilepsyMIB277
Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and managementNG206
Apalutamide with androgen deprivation therapy for treating high-risk hormone-relapsed non-metastatic prostate cancerTA740
Apalutamide with androgen deprivation therapy for treating hormone-sensitive metastatic prostate cancerTA741
Atezolizumab for untreated PD-L1-positive advanced urothelial cancer when cisplatin is unsuitableTA739
Genicular artery embolisation for pain from knee osteoarthritisIPG708
Laparoscopic renal denervation for loin pain haematuria syndromeIPG709
Percutaneous endovascular forearm arteriovenous fistula creation for haemodialysis accessIPG710
Tofacitinib for treating juvenile idiopathic arthritisTA735
Nivolumab for treating recurrent or metastatic squamous cell carcinoma of the head and neck after platinum-based chemotherapyTA736
Berotralstat for preventing recurrent attacks of hereditary angioedemaTA738
Looked-after children and young peopleNG205
Secukinumab for treating moderate to severe plaque psoriasis in children and young peopleTA734
Baloxavir marboxil for treating acute uncomplicated influenza (terminated appraisal)TA732
Inclisiran for treating primary hypercholesterolaemia or mixed dyslipidaemiaTA733
DyeVert Systems for reducing the risk of acute kidney injury in coronary and peripheral angiographyMTG60

Results per page

  1. 10
  2. 25
  3. 50
  4. All